Biomarkers · Cardiac & Hemodynamics

Heart-Type Fatty Acid-Binding Protein (H-FABP)

Lower values go with lower risk of death. No risk curve catalogued yet.

Published risk of death1.31×adjusted risk-of-death ratio per SD of heart-type fatty-acid-binding protein (95% CI 1.12–1.56) · Oxford Vascular Study: 929 consecutive patients with TIA or minor ischaemic stroke (population-based), recruited from 2002, followed to 2013

What else moves this marker

They describe those study groups, not an individual, and an association is not a cause.

Diseases and conditions

Each row is one study: what it compared and the change it reported in this marker.
What	Effect on the marker	Comparison · population	Source
↑ Abdominal aortic aneurysm (small/medium, 3.0-5.4 cm) · AAA without clinical CVD vs matched controls	+0.6 ng/mL	median 4.6 ug/L (AAA) vs 4.0 ug/L (controls) · 86 AAA patients and 158 age/sex-matched controls, all without history of clinical CVD	case control · PMID 24975961
↑ Mild cognitive impairment · MCI vs healthy controls, cerebrospinal fluid H-FABP	SMD +0.57 (95% CI 0.26 to 0.89)	MCI vs healthy controls (CSF) · 107 studies of CSF and peripheral neuronal-injury biomarkers in MCI	meta analysis · PMID 37647995

Sources

Greisenegger et al. Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study. Stroke. 2015;46:659-66.